Onconetix announces 1-for-10 reverse stock split effective May 21, 2026 to meet Nasdaq bid price rule

Onconetix, Inc.

Board fixed 1-for-10 reverse split ratio; effective 12:01 a.m. ET on May 21, 2026.
Reverse split reduces outstanding shares from ~11.4M to ~1.14M; no change in authorized shares or par value.
Split intended to regain compliance with Nasdaq $1.00 minimum bid price rule for continued listing.
No fractional shares issued; holders of fractional shares will receive cash compensation based on closing price on May 20, 2026.
Common stock continues trading on Nasdaq Capital Market under symbol ONCO with new CUSIP 68237Q 401.

item 5.03item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.